Fibrilation threshold curves and anti-arrhythmic drugs.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001949:Bretylium Compounds / Q000627:therapeutic use; D004285:Dogs; D004558:Electric Stimulation; D006919:Hydroxyzine / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000628:therapy; D011926:Rauwolfia / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D007093:Imidazoles; D006919:Hydroxyzine; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide